Drug Detail

Drug Name Oxaliplatin
Trade Name Eloxatin
Synonyms Diaminocyclohexane Oxalatoplatinum
Drug Descriptions

Eloxatin (oxaliplatin) is comprised of a platinum complex, which causes DNA-platinum cross-links, inhibition of DNA replication and transcription, and cell toxicity (NCI Drug Dictionary). Eloxatin (oxaliplatin) is FDA approved for colorectal cancer (FDA.gov).

DrugClasses Chemotherapy - Platinum 6

Filtering

  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"

Sorting

  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Therapy Description
Trastuzumab + Oxaliplatin
Gemcitabine + MT-3724 + Oxaliplatin MT-3724 is a cytotoxic antibody that targets CD20-expressing cells, which may block protein synthesis and induce apoptosis of tumor cells (PMID: 29559616).
Regorafenib + FOLFOX
BGB-A317 + Capecitabine + Oxaliplatin
NANT colorectal cancer vaccine combination
Panitumumab + Oxaliplatin + Fluorouracil
KX2-391 + Oxaliplatin
FOLFOX + Nivolumab + Relatlimab
Aflibercept + mFOLFOX-6
BGJ398 + Fluorouracil + Irinotecan + Oxaliplatin
Fluorouracil + Capecitabine + Irinotecan + Leucovorin + Oxaliplatin
DT01 + Fluorouracil + Oxaliplatin
Sorafenib + Bevacizumab + Oxaliplatin
Bevacizumab + MEDI4736 + Tremelimumab + FOLFOX
Palbociclib + Fluorouracil + Oxaliplatin
ON01910 + Oxaliplatin
Bevacizumab + Fluorouracil + Leucovorin + Oxaliplatin + NANT-008
Bevacizumab + Fluorouracil + Leucovorin + Oxaliplatin + Nivolumab
Floxuridine + Fluorouracil + Irinotecan + Leucovorin + Oxaliplatin + Panitumumab
Ad-CEA + Bevacizumab + FOLFOX
NANT pancreatic cancer vaccine combination
Panitumumab + Gemcitabine + Oxaliplatin
Oxaliplatin + ABT-737
Fluorouracil + Bevacizumab + Capecitabine + Leucovorin + Oxaliplatin
Oleclumab + mFOLFOX
Capecitabine + Epirubicin + Oxaliplatin + Pembrolizumab
AB928 + Oxaliplatin
MN58b + Oxaliplatin
CPI-613 + FOLFIRINOX
Nivolumab + mFOLFOX-6
Gemcitabine + Bevacizumab + Oxaliplatin
Bevacizumab + Capecitabine + Oxaliplatin + Trastuzumab
Panitumumab + Oxaliplatin + Fluorouracil + Irinotecan
Bevacizumab + Fluorouracil + Irinotecan + Oxaliplatin
FABLOx
Capecitabine + Nivolumab + Oxaliplatin
Irinotecan + Oxaliplatin + Cetuximab
mFOLFOX-6 + Pegilodecakin
Cetuximab + FOLFOX
Onartuzumab + mFOLFOX6
Capecitabine + Oxaliplatin + Bevacizumab
mFOLFOX-6 + Tivozanib
Axitinib + FOLFOX
Gemcitabine + MEK162 + Oxaliplatin
MEK162 + FOLFOX
Vandetanib + Capecitabine + Oxaliplatin
Bevacizumab + Cannabidiol + FOLFIRINOX
Durvalumab + Oleclumab + mFOLFOX
CV301 + Nivolumab + mFOLFOX6
INCB024360 + Nivolumab + mFOLFOX6
Bevacizumab + FOLFOX
Oxaliplatin + Trastuzumab + TS-1
mFOLFOX-6
Lapatinib + Oxaliplatin + Capecitabine
Bevacizumab + FOLFIRINOX
Gemcitabine + Nab-Paclitaxel + mFOLFOX-6
FOLFIRINOX + Losartan
Oxaliplatin
Necitumumab + FOLFOX
Capecitabine + Oxaliplatin + Pembrolizumab + Trastuzumab
Ch282-5 + Oxaliplatin
INCB001158 + FOLFOX
Ramucirumab + Oxaliplatin + TS-1
Bevacizumab + FOLFOX + Nab-Rapamycin
Binimetinib + Fluorouracil + Leucovorin + Oxaliplatin + Pembrolizumab
BSI-401 + Oxaliplatin
Cetuximab + FOLFIRINOX
Gemcitabine + Oxaliplatin + Rituximab
BGJ398 + Oxaliplatin
Gemcitabine + Oxaliplatin
Atezolizumab + Fluorouracil + Oxaliplatin
Vandetanib + FOLFOX
FOLFIRINOX + Losartan + Nivolumab
Oxaliplatin + Pembrolizumab + Trastuzumab + TS-1
Gemcitabine + Oxaliplatin + Sorafenib
mFOLFOX-6 + Atezolizumab + Cobimetinib
Fluorouracil + Oxaliplatin Eloxatin (oxaliplatin) is comprised of a platinum complex, which causes DNA-platinum cross-links, inhibition of DNA replication and transcription, and cell toxicity (NCI Drug Dictionary). Eloxatin (oxaliplatin) is FDA approved for colorectal cancer (FDA.gov).
Bevacizumab + Fluorouracil + Oxaliplatin
Fluorouracil + Leucovorin + Oxaliplatin + Pembrolizumab
Capecitabine + Oxaliplatin
FOLFIRINOX + Nivolumab
AB928 + mFOLFOX-6
Gemcitabine + Oxaliplatin + Dexamethasone
Cytarabine + Dexamethasone + Oxaliplatin
Bortezomib + Oxaliplatin
Bevacizumab + Atezolizumab + Fluorouracil + Leucovorin + Oxaliplatin
Oxaliplatin + Resminostat
Cetuximab + Dasatinib + FOLFOX
Ramucirumab + FOLFOX
Capecitabine + Nivolumab + Oxaliplatin + Relatlimab
FPA144 + Fluorouracil + Leucovorin + Oxaliplatin
Lapatinib + Oxaliplatin + Leucovorin + Fluorouracil
mFOLFOX-6 + Atezolizumab
Claudiximab + FOLFOX
Dbait + Fluorouracil + Oxaliplatin
Atezolizumab + Gemcitabine + Oxaliplatin + Rituximab
E7046 + mFOLFOX-6
Capecitabine + Oxaliplatin + Trastuzumab
Capecitabine + Fluorouracil + Talimogene laherparepvec + Oxaliplatin Imlygic (talimogene laherparepvec) is a GM-CSF expressing herpes simplex type-1 virus (HSV-1) that selectively infects and lyses tumor cells, and potentially induces a cytotoxic immune response against tumor cells (PMID: 25777572). Imlygic (talimogene laherparepvec) is FDA approved for use in patients with recurrent melanoma (FDA.gov).
Capecitabine + Oxaliplatin + Pembrolizumab
Panitumumab + FOLFOX
Fluorouracil + Leucovorin + Irinotecan + Oxaliplatin + Saridegib
Dasatinib + FOLFOX
FOLFIRINOX
Trastuzumab + Fluorouracil + Leucovorin + Oxaliplatin
Gemcitabine + Oxaliplatin + Nivolumab